SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950170-23-016264
Filing Date
2023-05-01
Accepted
2023-05-01 16:21:53
Documents
2

Document Format Files

Seq Description Document Type Size
1 DEFA14A vktx-2023-05-01-defa14a_.htm DEFA14A 14233
2 GRAPHIC img181408187_0.jpg GRAPHIC 178031
  Complete submission text file 0000950170-23-016264.txt   260551
Mailing Address 9920 PACIFIC HEIGHTS BLVD, SUITE 350 SAN DIEGO CA 92121
Business Address 9920 PACIFIC HEIGHTS BLVD, SUITE 350 SAN DIEGO CA 92121 858-704-4660
Viking Therapeutics, Inc. (Filer) CIK: 0001607678 (see all company filings)

IRS No.: 461073877 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37355 | Film No.: 23874000
SIC: 2834 Pharmaceutical Preparations